Search clinical trials for: WEX Pharmaceuticals

Total 14006 results

Spectrum Pharmaceuticals, Inc

Completed

Elsamitrucin (SPI 28090) for Relapsed or Refractory Non-Hodgkin's Lymphoma

Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

United States
Novartis

Completed

Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis

Atopic Dermatitis

United States
SciClone Pharmaceuticals

Completed

Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin

Hepatitis C | Hepatitis C, Chronic

United States, Puerto Rico
Javelin Pharmaceuticals

Completed

Efficacy and Safety of Intranasal Morphine for Pain After Elective Orthopedic Surgery

Pain, Postoperative

United States
Javelin Pharmaceuticals

Completed

Study to Assess the Safety, Tolerability and Pharmacokinetic Profile of MNS075 (Intranasal Morphine)

Healthy

United States
Javelin Pharmaceuticals

Completed

Efficacy and Safety of Intranasal Morphine for Pain After Bunion Surgery

Hallux Valgus
Javelin Pharmaceuticals

Completed

Absolute Bioavailability and Nasopharyngeal Absorption of Intranasal Ketamine

Healthy

United States
Javelin Pharmaceuticals

Completed

Multiple Dose Pharmacokinetics of Intranasal Ketamine

Healthy
Solvay Pharmaceuticals
Bristol-Myers Squibb

Withdrawn

BMS-646256 in Obese and Overweight Type 2 Diabetics

Obesity and Type 2 Diabetes
Jazz Pharmaceuticals

Completed

A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder

Anxiety Disorder

United States
Anthera Pharmaceuticals

Completed

PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease (PLASMA 2)

Coronary Artery Disease

United States
Javelin Pharmaceuticals

Completed

Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction

Post-Operative Pain | Third Molar Extraction
Javelin Pharmaceuticals

Completed

Study to Compare the Pharmacokinetics of IV Diclofenac Sodium (2 Doses)Versus Oral Diclofenac Potassium

Healthy

United States
Koronis Pharmaceuticals.

Completed

Study of KP-1461 for the Treatment of HIV Positive Patients Who Have Failed Multiple HAART Regimens

HIV Infections

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric Disorder

Menstruation Disturbances | Premenstrual Syndrome

United States, Canada
Ramsey, Bonnie, MD
Cystic Fibrosis Foundation; CF Therapeutics Development Network Coordinating... and other collaborators

Completed

Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis (SEER)

Cystic Fibrosis

United States
Vertex Pharmaceuticals Incorporated

Completed

Merimepodib (MMPD) in Triple Combination for the Treatment of Chronic Hepatitis C

Hepatitis | Hepatitis C

United States
Novartis

Completed

Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease

Alzheimer's Disease

United States
Callisto Pharmaceuticals

Unknown

Study of Liposomal Annamycin in Patients With Refractory or Relapsed Acute Lymphocytic Leukemia

Acute Lymphocytic Leukemia

United States
Callisto Pharmaceuticals

Completed

Safety and Efficacy of Atiprimod Treatment for Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

Neuroendocrine Carcinoma

United States
Callisto Pharmaceuticals

Completed

Safety and Efficacy of Atiprimod for Patients With Refractory Multiple Myeloma

Multiple Myeloma

United States
Vertex Pharmaceuticals Incorporated

Completed

VX-950 and Peginterferon for Hepatitis C

Hepatitis C

Germany, Netherlands
Vertex Pharmaceuticals Incorporated

Completed

Phase 2 Study of VX-950, Pegasys and Copegus in Hepatitis C

Hepatitis C

United States, Puerto Rico
Unither Pharmaceuticals

Terminated

Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment

Ovarian Cancer
Unither Pharmaceuticals

Terminated

Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma

Ovarian Neoplasms

Canada, United States
Unither Pharmaceuticals

Terminated

A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma

Ovarian Neoplasms

United States
Unither Pharmaceuticals

Terminated

Clinical Trial for Ovarian Cancer (OvaRex®)

Ovarian Cancer

United States
Astex Pharmaceuticals, Inc.
Eisai Inc.

Completed

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

Chronic Myelogenous Leukemia

United States, Canada
University of Pittsburgh
Elan Pharmaceuticals

Completed

Pharmacodynamic Parameters of Two Different Doses of Cefepime

Pneumonia | Bacteremia | Infection

United States
Vertex Pharmaceuticals Incorporated

Completed

Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702

Rheumatoid Arthritis

Poland, Croatia, Russian Federation, Bulgaria, Czech Republic, Former Serbia and Montenegro, Slovakia, Slovenia, Ukraine
Vertex Pharmaceuticals Incorporated

Completed

A Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702

Rheumatoid Arthritis

Bulgaria, Croatia, Former Serbia and Montenegro, Poland, Russian Federation, Slovenia
University of Washington
Aventis Pharmaceuticals

Completed

Taxotere Plus Weekly Navelbine and G-CSF: A Study in Stage IV Breast Cancer

Breast Neoplasm

United States
Vertex Pharmaceuticals Incorporated

Completed

Phase 2 Clinical Study in Psoriasis With Oral Investigational Drug VX-765

Psoriasis
Wyeth is now a wholly owned subsidiary of Pfizer
Solvay Pharmaceuticals

Completed

Study Evaluating Bifeprunox in Bipolar Depression

Depression Bipolar

United States
Alnylam Pharmaceuticals

Completed

Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus

Respiratory Syncytial Virus Infections

United States
Angiotech Pharmaceuticals

Completed

Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation

Myoma

Canada, Germany, Netherlands Antilles
Children's Hospital of Philadelphia
University of Pennsylvania; Women & Children's Hospital of Buffalo

Completed

Pilot Trial of Surfactant Therapy For Preterm Neonates 5-21 Days Old With Respiratory Decompensation

Respiratory Distress Syndrome
Solvay Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension

Hypertension

Italy
Epix Pharmaceuticals, Inc.

Completed

A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder

Major Depressive Disorder (MDD)

United States
Encysive Pharmaceuticals

Completed

Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension

Pulmonary Hypertension

United States
New River Pharmaceuticals

Completed

Safety, Tolerability and Abuse Liability Study of Intravenous NRP104 in Adults With Stimulant Abuse Histories

Substance-Related Disorders | Attention Deficit Disorder With Hyperactivity | Amphetamine-Related Disorders

United States
University of Saskatchewan
Gatorade Sports and Science Institute

Completed

The Combined Effects of Resistance Training and Flax Oil Supplementation Upon Inflammation in Older Adults

Inflammation | Sarcopenia

Canada
New River Pharmaceuticals

Completed

Study to Evaluate the Likeability, Safety, and Abuse Potential of NRP 104 in Adults With Histories of Stimulant Abuse

Substance-Related Disorders | Attention Deficit Disorder With Hyperactivity | Amphetamine-Related Disorders

United States
Validus Pharmaceuticals

Completed

Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder

Bipolar Disorder
Vanda Pharmaceuticals

Completed

VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness

Excessive Somnolence

France
Validus Pharmaceuticals

Completed

Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder

Bipolar Disorder
CPL Associates
Elan Pharmaceuticals

Completed

Cefepime vs. Ceftriaxone to Treat Nursing Home-Acquired Pneumonia

Pneumonia

United States
Institute of Cardiology, Warsaw, Poland
Solvay Pharmaceuticals

Completed

Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD Study

Coronary Artery Disease

Poland
Inflabloc Pharmaceuticals

Completed

An Efficacy and Safety Evaluation of Inflabloc Cap in the Treatment of Patients With Crohn's Disease

Crohn's Disease

United States, Canada
Ionis Pharmaceuticals, Inc.

Completed

Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715

Type 2 Diabetes Mellitus

United States

3

Subscribe